Skip to main content

Table 1 Demographic characteristics, CMT, and BCVA of study patients

From: The effects of intravitreal adalimumab injection on pseudophakic macular edema

Patient No Eye Sex BCVA1 BCVA2 BCVA3 CMT1 CMT2 CMT3
1 OD Female 0.52 0.52 0.52 464 505 356
2 OD Female 0.52 0.52 0.69 567 371 492 (422)
3 OS Male 1.77 1.77 1.77 968 410 394
4 OD Male 1.00 0.69 1.00 406 385 (413) 423
5 OD Female 0.69 0.69 512 571
  1. BCVA1 the logarithm of the minimum angle of resolution BCVA 1 day before injection, BCVA2 the logarithm of the minimum angle of resolution BCVA 1 week after injection; BCVA3 the logarithm of the minimum angle of resolution BCVA 1 month after injection, CMT1 central macular thickness 1 day before injection, CMT2 central macular thickness 1 week after injection, CMT3 central macular thickness 1 month after injection, OD right eye, OS left eye
\